Therapeutic effectiveness of carminomycin (CRM) in combination with dibromodulcitol (DBD) compared with the combination vincristine, cyclophosphamide, methotrexate, 5-fluorouracil (VCMF) on some tumor systems
Nowak, C.; Arnold, W.; Henneberger, G.; Tanneberger, S.
Archiv für Geschwulstforschung 50(8): 747-757
1980
ISSN/ISBN: 0003-911X PMID: 7224818 Document Number: 158973
The antineoplastic effectivity of VCMF was compared with the combined therapy CRM plus DBD in the mouse tumor systems L1210, 1142 A and Lewis lung carcinoma. Therapy of tumor-bearing mice was carried out by administering doses on the basis of LD 10 or with doses directly calculated from the clinical study CMEA 0102. In the most of all experiments VCMF was superior to the combination CRM plus DBD.
Document emailed within 1 workday
Related Documents
Raevskiĭ, I.G. 1976: Chemotherapy of inoperable breast cancer with a combination of 5-fluorouracil, methotrexate, vincristine, cyclophosphamide and prednisolone Sovetskaia Meditsina 8: 112-114Huang, H.; Lian, L.; Huang, R. 1995: Response of ovarian endodermal sinus tumor to combination chemotherapy with cis-platinum, vincristine and bleomycin or vincristine, actinomycin and cyclophosphamide Zhonghua Fu Chan Ke Za Zhi 30(5): 265-269
Tashiro, K.; Kondo, N.; Ikemoto, I. 1986: A case of complete remission of distant metastases of a renal pelvic tumor by combination chemotherapy with mitomycin, cyclophosphamide and 5-fluorouracil Hinyokika Kiyo. Acta Urologica Japonica 32(3): 449-453
Hainsworth, J.D.; Wolff, S.N.; Stein, R.S.; Greer, J.P.; Cousar, J.B.; Greco, F.A. 1986: Effects of Mega-COMLA (cyclophosphamide, cytarabine, vincristine, and methotrexate followed by leucovorin and prednisone) plus CHOP (cyclophosphamide, doxorubicin, vincristine, and prednisone) in the treatment of lymphoid neoplasms with very poor prognosis Cancer Treatment Reports 70(8): 953-958
Hansen, M.M.; Bloomfield, C.D.; Jørgensen, J.; Ersbøll, J.; Pedersen-Bjergaard, J.; Blom, J.; Nissen, N.I. 1980: VP-16-213 in combination with cyclophosphamide, doxorubicin, vincristine, and prednisone in the treatment of non-Hodgkin's lymphomas Cancer Treatment Reports 64(10-11): 1135-1137
Tirelli, U.; Carbone, A.; Veronesi, A.; Galligioni, E.; Trovò, M.G.; Tumolo, S.; Grigoletto, E. 1982: Combination chemotherapy with cyclophosphamide, vincristine, and prednisone (CVP) in TNM-classified stage IV mycosis fungoides Cancer Treatment Reports 66(1): 167-169
Taylor, S.G.; Desai, S.A.; DeWys, W.D. 1978: Phase Ii trial of a combination of cyclosphamide, vincristine, and methotrexate in advanced colorectal carcinoma Cancer Treatment Reports 62(8): 1203-1205
Adachi, K.; Ogawa, M.; Inagaki, J.; Horikoshi, N.; Inoue, K.; Ikeda, K.; Usui, N.; Nakata, H.; Tada, A.; Aiba, K. 1984: A combination chemotherapy consisting of vincristine, etoposide and cyclophosphamide (VEC) for small cell carcinoma of the lung Gan to Kagaku Ryoho. Cancer and ChemoTherapy 11(8): 1617-1622
Leone, G.; Pagano, L.; Marra, R.; Landolfi, R.; Cudillo, L.; Storti, S.; Mango, G.; Alfano, G.; D'Onofrio, G. 1987: Combination of 6-mercaptopurine, vincristine, methotrexate, and prednisone in resistant or relapsed acute nonlymphoid leukemia Cancer Treatment Reports 71(7-8): 751-753
Bernath, A.M.; Cohen, M.H.; Ihde, D.C.; Fossieck, B.E.; Matthews, M.J.; Minna, J.D. 1976: Combination chemotherapy with methyl-CCNU, 5-fluorouracil, and vincristine in adenocarcinoma and large cell carcinoma of the lung Cancer Treatment Reports 60(9): 1393-1394
Iskander, K.G.; Abusinna, I.M. 1988: Effect of cyclophosphamide, fluorouracil and their combination on dental caries in rats Egyptian Dental Journal 34(3): 273-285
Chello, P.L.; Sirotnak, F.M. 1981: Increased schedule-dependent synergism of vindesine versus vincristine in combination with methotrexate against L1210 leukemia Cancer Treatment Reports 65(11-12): 1049-1053
Konami, T.; Wakabayashi, Y.; Kim, T.; Ishida, A.; Arai, Y.; Konishi, T.; Pak, K.; Takeuchi, H.; Tomoyoshi, T.; Watanabe, J. 1989: Sequential combination chemotherapy consisting of vincristine, peplomycin, methotrexate, cis-diamminedichloroplatinum (II) and adriamycin in urothelial cancer Hinyokika Kiyo. Acta Urologica Japonica 35(2): 231-237
Samson, M.K.; Baker, L.H.; Fraile, R.J.; Izbicki, R.M.; Vaitkevicius, V.K. 1977: Combination chemotherapy with cyclophosphamide, vincristine, methyl-CCNU, and bleomycin in advanced bronchogenic carcinoma: experience with 106 patients Cancer Treatment Reports 61(1): 59-64
Closon, M.T.; Verbeke, L.; Kains, J.P.; Tijtgat, J.; Schallier, D. 1995: Combination chemotherapy with carboplatin, cyclophosphamide and fluorouracil in advanced breast cancer Anticancer Research 15(2): 591-595
Kano, Y.; Ohnuma, T.; Okano, T.; Holland, J.F. 1988: Effects of vincristine in combination with methotrexate and other antitumor agents in human acute lymphoblastic leukemia cells in culture Cancer Research 48(2): 351-356
Abe, O.; Izuo, M.; Enomoto, K.; Kubo, K.; Koyama, H.; Sakai, K.; Terasawa, T.; Tominaga, T.; Nomura, Y. 1982: Combination chemotherapy of cyclophosphamide adriamycin and 5-fluorouracil (CAF) in advanced and recurrent breast cancer Gan to Kagaku Ryoho. Cancer and ChemoTherapy 9(5): 866-873
Miller, A.B.; Klaassen, D.J.; Boyes, D.A.; Dodds, D.J.; Gerulath, A.; Kirk, M.E.; Levitt, M.; Pearson, J.G.; Wall, C. 1980: Combination v. sequential therapy with melphalan, 5-fluorouracil and methotrexate for advanced ovarian cancer Canadian Medical Association Journal 123(5): 365-371
Umsawasdi, T.; Chainuvati, T.; Hitanant, S.; Nilprabhassorn, P.; Viranuvatti, V. 1976: Combination chemotherapy with 5--fluorouracil, amethopterin (methotrexate) and prednisolone (FAP protocol) in the therapy of cholangiocarcinoma Journal of the Medical Association of Thailand 59(8): 380-383
Houghton, J.A.; Tice, A.J.; Houghton, P.J. 1982: The selectivity of action of methotrexate in combination with 5-fluorouracil in xenografts of human colon adenocarcinomas Molecular Pharmacology 22(3): 771-778